Janssen Biotech, Inc.
Clinical trials sponsored by Janssen Biotech, Inc., explained in plain language.
-
Simponi safety under the microscope in ulcerative colitis patients
Disease control OngoingThis study tracks the long-term safety of Simponi in 537 adults with moderate-to-severe ulcerative colitis. Researchers monitor serious side effects, including infections and cancers, while also checking how well the disease is controlled. Participants are already taking or about…
Sponsor: Janssen Biotech, Inc. • Aim: Disease control
Last updated May 26, 2026 08:42 UTC
-
Massive study tracks Kids' IBD for years – no new treatment, just Real-World data
Knowledge-focused OngoingThis study is a long-term registry that follows nearly 5,000 children with inflammatory bowel disease (Crohn's, ulcerative colitis, or indeterminate colitis) to monitor their safety and health over time. Researchers collect information on side effects from treatments like inflixi…
Sponsor: Janssen Biotech, Inc. • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:00 UTC